---
title: Asimov vs Minaris Advanced Therapies
slug_a: asimov
slug_b: wuxi-advanced-therapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/asimov/wuxi-advanced-therapies
---

# Asimov vs Minaris Advanced Therapies

Side-by-side profile data from each company listing on this directory.

## Asimov

- Profile: [/companies/asimov](/companies/asimov)

Asimov — Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.

Services: 11. Modalities: 5. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Cell-Free
- Single-Use / Disposable

## Minaris Advanced Therapies

- Profile: [/companies/wuxi-advanced-therapies](/companies/wuxi-advanced-therapies)

Minaris Advanced Therapies — Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.

Services: 15. Modalities: 6. Indications: 0. Locations: 14. Certifications: 6. The strongest documented coverage currently appears in services (15).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector